M1no-Study - Early Identification of Infants With High Type 1 Diabetes Risk for Participation in Primary Prevention Trials

ConditionType 1 Diabetes

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age0-6

SponsorIRCCS San Raffaele

About this trial

The goal of this observational study is to identify newborns at increased genetic risk of developing type 1 diabetes-specific beta-cell autoantibodies in order to determine eligibility for participation in primary prevention randomized controlled trials aimed at preventing beta-cell autoimmunity.

Eligibility criteria

Qualifiers

Screening is performed between the ages of 0 and 6 weeks.

Consent form signed by parents/guardian.

Disqualifiers

Infants aged above 6 weeks.

Refusal to participate in the study

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

IRCCS San Raffaele

Lead sponsor

Clinica Mangiagalli

Collaborator

Azienda Ospedaliero-Universitaria Maggiore della Carità di Novara

Collaborator

Azienda Socio Sanitaria Territoriale di Lecco

Collaborator

Ospedale F. Del Ponte, Varese

Collaborator

Source ClinicalTrials.gov